Trastuzumab News and Research

RSS
New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

New technology tricks tumors to eliminate itself through the production of anti-cancer agents

New technology tricks tumors to eliminate itself through the production of anti-cancer agents

The Christie NHS Foundation Trust first to offer treatment in cancer patients’ homes

The Christie NHS Foundation Trust first to offer treatment in cancer patients’ homes

Cholesterol-lowering drugs may protect women's hearts from damage caused during chemotherapy

Cholesterol-lowering drugs may protect women's hearts from damage caused during chemotherapy

Statins may protect the heart from damaging side-effects of early breast cancer treatment

Statins may protect the heart from damaging side-effects of early breast cancer treatment

Researchers identify a potential target for small cell lung cancer

Researchers identify a potential target for small cell lung cancer

Patients with invasive lobular carcinoma could benefit from additional adjuvant therapy

Patients with invasive lobular carcinoma could benefit from additional adjuvant therapy

New material identifies cancer cells and mounts a surprising attack

New material identifies cancer cells and mounts a surprising attack

Sub-Saharan Africa needs greater access to live-saving antibodies

Sub-Saharan Africa needs greater access to live-saving antibodies

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Combination therapy improves survival rates for women with aggressive endometrial cancer

Combination therapy improves survival rates for women with aggressive endometrial cancer

Rice lab's fluorescent tag project reveals new method to kill tumors

Rice lab's fluorescent tag project reveals new method to kill tumors

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Statins may protect against heart damage caused by breast cancer therapies

Statins may protect against heart damage caused by breast cancer therapies

Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

NCCN publishes recommendations for assessing quality improvements in cancer care

NCCN publishes recommendations for assessing quality improvements in cancer care